AGM results statement June 2018 Paris, France and Cambridge, UK – 12 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, yesterday held its Annual General Meeting (AGM). The results of the AGM are set out in the table below, with the Company pleased to announce that all resolutions
Visit PageCategory: NOVAPREP®
NOVACYT LAUNCHES NEW PRODUCT IN INFECTIOUS MONONUCLEOSIS
New product launch under PathFlow brand First in a series of new product launches in infectious diseases
Visit PageNovacyt provides a business update
business-update-pr-eng Expanding NovaPrep commercialisation activities Investment in key growth regions
Visit Page